Patrick J. Heron, Director at Mirum Pharmaceuticals, Inc. (MIRM), bought 2,881 shares at $45.55 ($131K) on 2025-03-04, disclosed to the SEC on 2025-03-06.
Open-market purchase of $131k MIRM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.55 | 1,279 | $58K | 44.5% |
| 2 | $45.55 | 1,279 | $58K | 44.5% |
| 3 | $45.96 | 56 | $3K | 2.0% |
| 4 | $44.55 | 267 | $12K | 9.1% |
| Total | $45.47 avg | 2,881 | $131K | 100% |
| Filing → |
| ARQT | BUY | 2025-06-06 | $30K | — | Filing → |
| ARQT | BUY | 2025-05-23 | $69K | — | Filing → |
| ARQT | BUY | 2025-05-19 | $34K | — | Filing → |